Skip to content
healthcare.dev

Ranolazine

NDC 50268-722, Ranolazine, tablet, film coated, extended release, from AvPAK.

Product NDC
50268-722
Status
Listed
Labeler
AvPAK
Dosage form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA209953
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/50268-722 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • RANOLAZINE500 mg/1

Pharmacologic classes

Anti-anginal [EPC]; Cytochrome P450 2D6 Inhibitors [MoA]; Cytochrome P450 3A Inhibitors [MoA]; Organic Cation Transporter 2 Inhibitors [MoA]; P-Glycoprotein Inhibitors [MoA]

Package NDCNDC-11Package
50268-722-155026807221550 BLISTER PACK in 1 BOX (50268-722-15) / 1 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK (50268-722-11)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/e92350e8-5b0b-95d3-e053-2995a90a959b
  • NADAC price for package 50268072215

    GET /v1/drugs/nadac/50268072215

Use it

Look up 50268-722 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/50268-722 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 50268-722. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.